Spaces:
Running
on
Zero
Running
on
Zero
Update model descriptions in the Gradio app
Browse files
app.py
CHANGED
@@ -64,24 +64,21 @@ description_md = """
|
|
64 |
This tool accepts protein sequences in FASTA format
|
65 |
|
66 |
**🧾 Output Explanation**
|
67 |
-
|
68 |
AllerTrans classifies your input sequence into one of the following categories:
|
69 |
|
70 |
-
|
71 |
The protein is unlikely to cause an allergic reaction and can be considered safe in terms of allergenicity.
|
72 |
|
73 |
-
|
74 |
The protein has the potential to trigger an allergic response or exhibit cross-reactivity in certain individuals. While not all individuals may experience reactions, these proteins cannot be considered safe.
|
75 |
|
76 |
**💡 Accepted Proteins**
|
77 |
-
|
78 |
|
79 |
-
🔎 **Note of Caution**:
|
80 |
-
While our model demonstrates promising performance—particularly with recombinant proteins, as evidenced by our additional evaluation with a recombinant protein dataset
|
81 |
-
from UniProt—**we advise caution when generalizing the results to all constructs and modifications of recombinant protein**. The generizability of the model to various recombinant scenarios has not been fully explored.
|
82 |
|
83 |
-
|
84 |
-
Although AllerTrans provides highly accurate predictions, it is intended as a screening tool. For clinical or regulatory decisions, always confirm results with experimental validation.
|
85 |
"""
|
86 |
|
87 |
demo = gr.Interface(fn=classify,
|
|
|
64 |
This tool accepts protein sequences in FASTA format
|
65 |
|
66 |
**🧾 Output Explanation**
|
|
|
67 |
AllerTrans classifies your input sequence into one of the following categories:
|
68 |
|
69 |
+
**🟢 Non-Allergen**
|
70 |
The protein is unlikely to cause an allergic reaction and can be considered safe in terms of allergenicity.
|
71 |
|
72 |
+
**🔴 Potential Allergen**
|
73 |
The protein has the potential to trigger an allergic response or exhibit cross-reactivity in certain individuals. While not all individuals may experience reactions, these proteins cannot be considered safe.
|
74 |
|
75 |
**💡 Accepted Proteins**
|
76 |
+
Natural and also recombinant proteins
|
77 |
|
78 |
+
🔎 **Note of Caution & Disclaimer**:
|
79 |
+
While our model demonstrates promising performance—particularly with recombinant proteins, as evidenced by our additional evaluation with a recombinant protein dataset from UniProt—**we advise caution when generalizing the results to all constructs and modifications of recombinant proteins**. The generalizability of the model to various recombinant scenarios has not been fully explored.
|
|
|
80 |
|
81 |
+
AllerTrans is intended as a screening tool. For clinical or regulatory decisions, always confirm results with experimental validation.
|
|
|
82 |
"""
|
83 |
|
84 |
demo = gr.Interface(fn=classify,
|